{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:09:59Z","timestamp":1792102199143,"version":"4.4.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"CHRU de Tours"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00134-025-08252-x","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:19:24Z","timestamp":1768205964000},"page":"118-130","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Severe community-acquired pneumonia: current concepts and controversies"],"prefix":"10.1007","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4819-1769","authenticated-orcid":false,"given":"Pierre-Fran\u00e7ois","family":"Dequin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bassetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos J.","family":"Giamarellos-Bourboulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Martin-Loeches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco Umberto","family":"Meduri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Niederman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiagozie Ifeoma","family":"Pickens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"P\u00f3voa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"8252_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41572-021-00259-0","volume":"7","author":"A Torres","year":"2021","unstructured":"Torres A, Cilloniz C, Niederman MS et al (2021) Pneumonia. Nat Rev Dis Primers 7:25. https:\/\/doi.org\/10.1038\/s41572-021-00259-0","journal-title":"Nat Rev Dis Primers"},{"key":"8252_CR2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1183\/09031936.99.13234999","volume":"13","author":"J Almirall","year":"1999","unstructured":"Almirall J, Bol\u00edbar I, Balanz\u00f3 X et al (1999) Risk factors for community-acquired pneumonia in adults: a population-based case-control study. Eur Respir J 13:349\u2013355. https:\/\/doi.org\/10.1183\/09031936.99.13234999","journal-title":"Eur Respir J"},{"key":"8252_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191721","volume":"13","author":"M Ferrer","year":"2018","unstructured":"Ferrer M, Travierso C, Cilloniz C et al (2018) Severe community-acquired pneumonia: characteristics and prognostic factors in ventilated and non-ventilated patients. PLoS ONE 13:e0191721. https:\/\/doi.org\/10.1371\/journal.pone.0191721","journal-title":"PLoS ONE"},{"key":"8252_CR4","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.chest.2020.03.051","volume":"158","author":"R Cavallazzi","year":"2020","unstructured":"Cavallazzi R, Furmanek S, Arnold FW et al (2020) The Burden of community-acquired pneumonia requiring admission to ICU in the United States. Chest 158:1008\u20131016. https:\/\/doi.org\/10.1016\/j.chest.2020.03.051","journal-title":"Chest"},{"key":"8252_CR5","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00134-023-07033-8","volume":"49","author":"I Martin-Loeches","year":"2023","unstructured":"Martin-Loeches I, Torres A, Nagavci B et al (2023) ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia. Intensive Care Med 49:615\u2013632. https:\/\/doi.org\/10.1007\/s00134-023-07033-8","journal-title":"Intensive Care Med"},{"key":"8252_CR6","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","volume":"200","author":"JP Metlay","year":"2019","unstructured":"Metlay JP, Waterer GW, Long AC et al (2019) Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med 200:e45\u2013e67. https:\/\/doi.org\/10.1164\/rccm.201908-1581ST","journal-title":"Am J Respir Crit Care Med"},{"key":"8252_CR7","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202507-1692ST","author":"BE Jones","year":"2025","unstructured":"Jones BE, Ramirez JA, Oren E et al (2025) Diagnosis and management of community-acquired pneumonia: an official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. https:\/\/doi.org\/10.1164\/rccm.202507-1692ST","journal-title":"Am J Respir Crit Care Med"},{"key":"8252_CR8","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1093\/cid\/cix647","volume":"65","author":"J Ramirez","year":"2017","unstructured":"Ramirez J, Wiemken TL, Peyrani P et al (2017) Adults hospitalized with pneumonia in the United States: incidence, epidemiology and mortality. Clin Infect Dis 65:1806\u20131812. https:\/\/doi.org\/10.1093\/cid\/cix647","journal-title":"Clin Infect Dis"},{"key":"8252_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1056\/NEJM199701233360402","volume":"336","author":"MJ Fine","year":"1997","unstructured":"Fine MJ, Auble TE, Yealy DM et al (1997) A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336:243\u2013250. https:\/\/doi.org\/10.1056\/NEJM199701233360402","journal-title":"N Engl J Med"},{"key":"8252_CR10","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/thorax.58.5.377","volume":"58","author":"WS Lim","year":"2003","unstructured":"Lim WS, van der Eerden MM, Laing R et al (2003) Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58:377\u2013382. https:\/\/doi.org\/10.1136\/thorax.58.5.377","journal-title":"Thorax"},{"key":"8252_CR11","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1086\/589754","volume":"47","author":"PG Charles","year":"2008","unstructured":"Charles PG, Wolfe R, Whitby M et al (2008) SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis 47:375\u2013384. https:\/\/doi.org\/10.1086\/589754","journal-title":"Clin Infect Dis"},{"key":"8252_CR12","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1056\/NEJMcp2303286","volume":"389","author":"TM File Jr","year":"2023","unstructured":"File TM Jr, Ramirez JA (2023) Community-acquired pneumonia. N Engl J Med 389:632\u2013641. https:\/\/doi.org\/10.1056\/NEJMcp2303286","journal-title":"N Engl J Med"},{"key":"8252_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.21037\/arh.2018.04.02","volume":"2","author":"D Viasus","year":"2018","unstructured":"Viasus D, Cil\u00f3niz C, Cardoso CG et al (2018) Early, short and long-term mortality in community-acquired pneumonia. Ann Res Hosp 2:5. https:\/\/doi.org\/10.21037\/arh.2018.04.02","journal-title":"Ann Res Hosp"},{"key":"8252_CR14","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s13054-023-04466-x","volume":"27","author":"LF Reyes","year":"2023","unstructured":"Reyes LF, Garcia E, Ib\u00e1\u00f1es-Prada ED et al (2023) Impact of macrolide treatment on long-term mortality in patients admitted to the ICU due to CAP: a targeted maximum likelihood estimation and survival analysis. Crit Care 27:212. https:\/\/doi.org\/10.1186\/s13054-023-04466-x","journal-title":"Crit Care"},{"key":"8252_CR15","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1056\/NEJMoa1500245","volume":"373","author":"S Jain","year":"2015","unstructured":"Jain S, Self WH, Wunderink RG et al (2015) Community-acquired pneumonia requiring hospitalization among US adults. N Engl J Med 373:415\u2013422. https:\/\/doi.org\/10.1056\/NEJMoa1500245","journal-title":"N Engl J Med"},{"key":"8252_CR16","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1186\/s12879-018-3366","volume":"18","author":"J Quah","year":"2018","unstructured":"Quah J, Jiang B, Tan PC, Siau C, Tan TY (2018) Impact of microbial aetiology on mortality in severe community-acquired pneumonia. BMC Infect Dis 18:451. https:\/\/doi.org\/10.1186\/s12879-018-3366","journal-title":"BMC Infect Dis"},{"key":"8252_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13613-024-01252-y","volume":"14","author":"J Rello","year":"2024","unstructured":"Rello J, Allam C, Ruiz-Spinelli A, Jarraud S (2024) Severe Legionnaire\u2019s disease. Ann Intensive Care 14:51. https:\/\/doi.org\/10.1186\/s13613-024-01252-y","journal-title":"Ann Intensive Care"},{"key":"8252_CR18","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1007\/s10096-020-03870-3","volume":"39","author":"M Carugati","year":"2020","unstructured":"Carugati M, Aliberti S, Sotgiu G et al (2020) Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study. Eur J Clin Microbiol Infect Dis 39:1513\u20131525. https:\/\/doi.org\/10.1007\/s10096-020-03870-3","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"8252_CR19","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/S1473-3099(16)30267-5","volume":"16","author":"S Aliberti","year":"2016","unstructured":"Aliberti S, Reyes LF, Faverio P et al (2016) Global initiative for andomized-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. Lancet Infect Dis 16:1364\u20131376. https:\/\/doi.org\/10.1016\/S1473-3099(16)30267-5","journal-title":"Lancet Infect Dis"},{"key":"8252_CR20","doi-asserted-by":"publisher","first-page":"1701190","DOI":"10.1183\/13993003.01190-2017","volume":"52","author":"MI Restrepo","year":"2018","unstructured":"Restrepo MI, Babu BL, Reyes LF et al (2018) Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalized patients. Eur Respir J 52:1701190. https:\/\/doi.org\/10.1183\/13993003.01190-2017","journal-title":"Eur Respir J"},{"key":"8252_CR21","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/resp.13663","volume":"25","author":"D Villafuerte","year":"2020","unstructured":"Villafuerte D, Aliberti S, Soni NJ et al (2020) Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia. Respirology 25:543\u2013551. https:\/\/doi.org\/10.1111\/resp.13663","journal-title":"Respirology"},{"key":"8252_CR22","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1056\/NEJMra1714562","volume":"380","author":"LA Mandell","year":"2019","unstructured":"Mandell LA, Niederman MS (2019) Aspiration pneumonia. N Engl J Med 380:651\u2013663. https:\/\/doi.org\/10.1056\/NEJMra1714562","journal-title":"N Engl J Med"},{"key":"8252_CR23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.chest.2020.06.079","volume":"159","author":"J Marin-Corral","year":"2021","unstructured":"Marin-Corral J, Pascal-Guardia S, Amati F et al (2021) Aspiration risk factors, microbiology, and empiric antibiotics for patients hospitalized with community-acquired pneumonia. Chest 159:68\u201372. https:\/\/doi.org\/10.1016\/j.chest.2020.06.079","journal-title":"Chest"},{"key":"8252_CR24","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1093\/cid\/ciy631","volume":"68","author":"T Maruyama","year":"2019","unstructured":"Maruyama T, Fujisawa T, Ishida T et al (2019) A therapeutic strategy for all pneumonia patients: a 3-year prospective multicenter-cohort study using risk factors for multidrug resistant pathogens to select initial empiric therapy. Clin Infect Dis 68:1080\u20131088. https:\/\/doi.org\/10.1093\/cid\/ciy631","journal-title":"Clin Infect Dis"},{"key":"8252_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1513\/AnnalsATS.201407-305OC","volume":"12","author":"E Prina","year":"2015","unstructured":"Prina E, Ranzani OT, Polverino E et al (2015) Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia. Ann Am Thor Soc 12:153\u2013160. https:\/\/doi.org\/10.1513\/AnnalsATS.201407-305OC","journal-title":"Ann Am Thor Soc"},{"key":"8252_CR26","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01023-22","volume":"67","author":"NJ Rhodes","year":"2023","unstructured":"Rhodes NJ, Rohani R, Yarnold PR et al (2023) Machine learning to stratify methicillin-resistant Staphylococcus aureus risk among hospitalized patients with community-acquired pneumonia. Antimicrob Agents Chemother 67:e0102322. https:\/\/doi.org\/10.1128\/aac.01023-22","journal-title":"Antimicrob Agents Chemother"},{"key":"8252_CR27","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3390\/arm91030018","volume":"91","author":"F Amati","year":"2023","unstructured":"Amati F, Bindo F, Stainer A et al (2023) Identify drug-resistant pathogens in patients with community-acquired pneumonia. Adv Respir Med 91:224\u2013238. https:\/\/doi.org\/10.3390\/arm91030018","journal-title":"Adv Respir Med"},{"key":"8252_CR28","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1001\/archinte.167.15.1655","volume":"167","author":"JA Kellum","year":"2007","unstructured":"Kellum JA, Kong L, Fink MP et al (2007) Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med 167:1655\u20131663. https:\/\/doi.org\/10.1001\/archinte.167.15.1655","journal-title":"Arch Intern Med"},{"key":"8252_CR29","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1183\/09031936.00040710","volume":"37","author":"R Martinez","year":"2011","unstructured":"Martinez R, Menendez R, Reyes S et al (2011) Factors associated with inflammatory cytokine patterns in community-acquired pneumonia. Eur Respir J 37:393\u2013399. https:\/\/doi.org\/10.1183\/09031936.00040710","journal-title":"Eur Respir J"},{"key":"8252_CR30","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jcrc.2011.02.001","volume":"26","author":"JI Salluh","year":"2011","unstructured":"Salluh JI, Rabello LS, Rosolem MM et al (2011) The impact of coagulation parameters on the outcomes of patients with severe community-acquired pneumonia requiring intensive care unit admission. J Crit Care 26:406\u2013501. https:\/\/doi.org\/10.1016\/j.jcrc.2011.02.001","journal-title":"J Crit Care"},{"key":"8252_CR31","doi-asserted-by":"publisher","first-page":"438","DOI":"10.2119\/molmed.2009.00091","volume":"15","author":"EB Milbrandt","year":"2009","unstructured":"Milbrandt EB, Reade MC, Lee M et al (2009) Prevalence and significance of coagulation abnormalities in community-acquired pneumonia. Mol Med 15:438\u2013445. https:\/\/doi.org\/10.2119\/molmed.2009.00091","journal-title":"Mol Med"},{"key":"8252_CR32","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1164\/rccm.200712-1777OC","volume":"177","author":"S Yende","year":"2008","unstructured":"Yende S, D\u2019Angelo G, Kellum JA et al (2008) Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis. Am J Respir Crit Care Med 177:1242\u20131247. https:\/\/doi.org\/10.1164\/rccm.200712-1777OC","journal-title":"Am J Respir Crit Care Med"},{"key":"8252_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022847","volume":"6","author":"S Yende","year":"2011","unstructured":"Yende S, D\u2019Angelo G, Florian M et al (2011) Elevated hemostasis markers after pneumonia increases one-year risk of allcause and cardiovascular deaths. PLoS ONE 6:e22847. https:\/\/doi.org\/10.1371\/journal.pone.0022847","journal-title":"PLoS ONE"},{"issue":"Suppl 1","key":"8252_CR34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40635-020-00316-0","volume":"8","author":"X Zhang","year":"2020","unstructured":"Zhang X, Zink F, Hezel F et al (2020) Metabolic substrate utilization in stress-induced immune cells. Intensive Care Med Exp 8(Suppl 1):28. https:\/\/doi.org\/10.1186\/s40635-020-00316-0","journal-title":"Intensive Care Med Exp"},{"key":"8252_CR35","doi-asserted-by":"publisher","DOI":"10.37349\/eemd.2025.101426","volume":"2","author":"GU Meduri","year":"2025","unstructured":"Meduri GU (2025) Glucocorticoid receptor alpha: origins and functions of the master regulator of homeostatic corrections in health and critical illness. Explor Endocr Metab Dis 2:101426. https:\/\/doi.org\/10.37349\/eemd.2025.101426","journal-title":"Explor Endocr Metab Dis"},{"key":"8252_CR36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1096\/fj.01-0245com","volume":"16","author":"J Galon","year":"2002","unstructured":"Galon J, Franchimont D, Hiroi N et al (2002) Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. Faseb J 16:61\u201371. https:\/\/doi.org\/10.1096\/fj.01-0245com","journal-title":"Faseb J"},{"key":"8252_CR37","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.1210\/en.2012-1020","volume":"153","author":"EA Lannan","year":"2012","unstructured":"Lannan EA, Galliher-Beckley AJ et al (2012) Proinflammatory actions of glucocorticoids: glucocorticoids and TNF\u03b1 coregulate gene expression in vitro and in vivo. Endocrinology 153:3701\u20133712. https:\/\/doi.org\/10.1210\/en.2012-1020","journal-title":"Endocrinology"},{"key":"8252_CR38","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/SHK.0000000000001252","volume":"52","author":"M Ballegeer","year":"2019","unstructured":"Ballegeer M, Vandewalle J, Eggermont M et al (2019) Overexpression of gilz protects mice against lethal septic peritonitis. Shock 52:208\u2013214. https:\/\/doi.org\/10.1097\/SHK.0000000000001252","journal-title":"Shock"},{"key":"8252_CR39","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nri.2017.1","volume":"17","author":"DW Cain","year":"2017","unstructured":"Cain DW, Cidlowski JA (2017) Immune regulation by glucocorticoids. Nat Rev Immunol 17:233\u2013247. https:\/\/doi.org\/10.1038\/nri.2017.1","journal-title":"Nat Rev Immunol"},{"key":"8252_CR40","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1136\/thorax-2024-222296","volume":"80","author":"I Martin-Loeches","year":"2025","unstructured":"Martin-Loeches I, Reyes LF, Rodriguez A (2025) Severe community-acquired pneumonia (SCAP): advances in management and future directions. Thorax 80:565\u2013575. https:\/\/doi.org\/10.1136\/thorax-2024-222296","journal-title":"Thorax"},{"key":"8252_CR41","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1183\/13993003.00191-2016","volume":"48","author":"A Liapikou","year":"2016","unstructured":"Liapikou A, Cilloniz C, Gabarrus A et al (2016) Multilobar bilateral and unilateral chest radiograph involvement: implications for prognosis in community-acquired pneumonia. Eur Respir J 48:257\u2013261. https:\/\/doi.org\/10.1183\/13993003.00191-2016","journal-title":"Eur Respir J"},{"key":"8252_CR42","doi-asserted-by":"publisher","first-page":"382.e1","DOI":"10.1016\/j.cmi.2019.06.026","volume":"26","author":"P Loubet","year":"2020","unstructured":"Loubet P, Tubiana S, Claessens YE et al (2020) Community-acquired pneumonia in the emergency department: an algorithm to facilitate diagnosis and guide chest CT scan indication. Clin Microbiol Infect 26:382.e1-382.e7. https:\/\/doi.org\/10.1016\/j.cmi.2019.06.026","journal-title":"Clin Microbiol Infect"},{"key":"8252_CR43","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-036067","volume":"10","author":"JJ Str\u00f8m","year":"2020","unstructured":"Str\u00f8m JJ, Sperling Haugen P, Plejdrup Hansen M et al (2020) Accuracy of lung ultrasonography in the hands of non-imaging specialists to diagnose and assess the severity of community-acquired pneumonia in adults: a systematic review. BMJ Open 10:e036063. https:\/\/doi.org\/10.1136\/bmjopen-2019-036067","journal-title":"BMJ Open"},{"key":"8252_CR44","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/CPM.0000000000000322","volume":"26","author":"P P\u00f3voa","year":"2019","unstructured":"P\u00f3voa P, Coelho L, Bos LD (2019) Biomarkers in pulmonary infections. Clin Pulm Med 26:118\u2013125. https:\/\/doi.org\/10.1097\/CPM.0000000000000322","journal-title":"Clin Pulm Med"},{"key":"8252_CR45","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/S00134-022-06956-Y","volume":"49","author":"P P\u00f3voa","year":"2023","unstructured":"P\u00f3voa P, Coelho L, Dal-Pizzol F et al (2023) How to use biomarkers of infection or sepsis at the bedside: guide to clinicians. Intensive Care Med 49:142\u2013153. https:\/\/doi.org\/10.1007\/S00134-022-06956-Y","journal-title":"Intensive Care Med"},{"key":"8252_CR46","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1164\/rccm.201709-1908OC","volume":"198","author":"R M\u00e9ndez","year":"2018","unstructured":"M\u00e9ndez R, Men\u00e9ndez R, Cill\u00f3niz C et al (2018) Initial inflammatory profile in community-acquired pneumonia depends on time since onset of symptoms. Am J Respir Crit Care Med 198:370\u2013378. https:\/\/doi.org\/10.1164\/rccm.201709-1908OC","journal-title":"Am J Respir Crit Care Med"},{"key":"8252_CR47","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1164\/rccm.201501-0017OC","volume":"192","author":"YE Claessens","year":"2015","unstructured":"Claessens YE, Debray MP, Tubach F et al (2015) Early chest computed tomography scan to assist diagnosis and guide treatment decision for suspected community-acquired pneumonia. Am J Respir Crit Care Med 192:974\u2013982. https:\/\/doi.org\/10.1164\/rccm.201501-0017OC","journal-title":"Am J Respir Crit Care Med"},{"key":"8252_CR48","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s00134-018-5228-3","volume":"44","author":"M Parlato","year":"2018","unstructured":"Parlato M, Philippart F, Rouquette A et al (2018) Circulating biomarkers may be unable to detect infection at the early phase of sepsis in ICU patients: the CAPTAIN prospective multicenter cohort study. Intensive Care Med 44:1061\u20131070. https:\/\/doi.org\/10.1007\/s00134-018-5228-3","journal-title":"Intensive Care Med"},{"key":"8252_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/cc6105","volume":"11","author":"L Coelho","year":"2007","unstructured":"Coelho L, P\u00f3voa P, Almeida E et al (2007) Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course. Crit Care 11:1\u20139. https:\/\/doi.org\/10.1186\/cc6105","journal-title":"Crit Care"},{"key":"8252_CR50","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jcrc.2017.07.021","volume":"42","author":"LSCF Rabello","year":"2017","unstructured":"Rabello LSCF, P\u00f3voa P, Lapa E Silva JR et al (2017) Patterns of C-reactive protein ratio predicts outcomes in healthcare-associated pneumonia in critically ill patients with cancer. J Crit Care 42:231\u2013237. https:\/\/doi.org\/10.1016\/j.jcrc.2017.07.021","journal-title":"J Crit Care"},{"issue":"9782","key":"8252_CR51","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(11)60607-7","volume":"377","author":"SC Meijivis","year":"2011","unstructured":"Meijivis SC, Hardeman H, Remmelts HH et al (2011) Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomized, double-blind, placebo-controlled trial. Lancet 377(9782):2023\u20132030. https:\/\/doi.org\/10.1016\/S0140-6736(11)60607-7","journal-title":"Lancet"},{"key":"8252_CR52","doi-asserted-by":"publisher","first-page":"R96","DOI":"10.1186\/cc10103","volume":"15","author":"S Fern\u00e1ndez-Serrano","year":"2011","unstructured":"Fern\u00e1ndez-Serrano S, Dorca J, Garcia-Vidal C et al (2011) Effects of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial. Crit Care 15:R96. https:\/\/doi.org\/10.1186\/cc10103","journal-title":"Crit Care"},{"key":"8252_CR53","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1164\/rccm.200512-1922OC","volume":"174","author":"M Christ-Crain","year":"2006","unstructured":"Christ-Crain M, Stolz D, Bingisser R et al (2006) Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 174:84\u201393. https:\/\/doi.org\/10.1164\/rccm.200512-1922OC","journal-title":"Am J Respir Crit Care Med"},{"key":"8252_CR54","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-025-08014-9","author":"G Voiriot","year":"2025","unstructured":"Voiriot G, Argaud L, Cohen Y et al (2025) Combined use of a multiplex PCR and serum procalcitonin to reduce antibiotic exposure in critically ill patients with community-acquired pneumonia: the MULTI-CAP randomized controlled trial. Intensive Care Med. https:\/\/doi.org\/10.1007\/s00134-025-08014-9. (online ahead of print)","journal-title":"Intensive Care Med"},{"key":"8252_CR55","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1097\/CCM.0000000000004267","volume":"48","author":"N Arulkumaran","year":"2020","unstructured":"Arulkumaran N, Khpal M, Tam K et al (2020) Effect of antibiotic discontinuation strategies on mortality and infectious complications in critically ill septic patients: a meta-analysis and trial sequential analysis. Crit Care Med 48:757\u2013764. https:\/\/doi.org\/10.1097\/CCM.0000000000004267","journal-title":"Crit Care Med"},{"key":"8252_CR56","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s00134-025-07903-3","volume":"51","author":"P Povoa","year":"2025","unstructured":"Povoa P, Coelho L, Carratala J et al (2025) How to approach a patient hospitalized for pneumonia who is not responding to treatment? Intensive Care Med 51:893\u2013903. https:\/\/doi.org\/10.1007\/s00134-025-07903-3","journal-title":"Intensive Care Med"},{"key":"8252_CR57","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1378\/chest.121.5.1486","volume":"121","author":"S Ewig","year":"2002","unstructured":"Ewig S, Schlochtermeier M, G\u00f6ke N, Niederman MS (2002) Applying sputum as a diagnostic tool in pneumonia: limited yield, minimal impact on treatment decisions. Chest 121:1486\u20131492. https:\/\/doi.org\/10.1378\/chest.121.5.1486","journal-title":"Chest"},{"issue":"suppl 68","key":"8252_CR58","doi-asserted-by":"publisher","first-page":"PA5063","DOI":"10.1183\/13993003.congress-2024.PA5063","volume":"64","author":"S Etienne","year":"2024","unstructured":"Etienne S, Albrich W, Pletz M et al (2024) Diagnostic yield of BAL vs. non-invasive analysis in patients with CAP. Eur Respir J 64(suppl 68):PA5063. https:\/\/doi.org\/10.1183\/13993003.congress-2024.PA5063","journal-title":"Eur Respir J"},{"key":"8252_CR59","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13054-019-2348-2","volume":"23","author":"OT Ranzani","year":"2019","unstructured":"Ranzani OT, Senussi T, Idone F et al (2019) Invasive and non-invasive diagnostic approaches for microbiological diagnosis of hospital-acquired pneumonia. Crit Care 23:51. https:\/\/doi.org\/10.1186\/s13054-019-2348-2","journal-title":"Crit Care"},{"key":"8252_CR60","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1186\/s13054-024-05224-3","volume":"28","author":"FJ Candel","year":"2024","unstructured":"Candel FJ, Salavert M, Cant\u00f3n R et al (2024) The role of multiplex molecular syndromic panels in the clinical management of infections in critically ill patients: an experts-opinion document. Crit Care 28:440. https:\/\/doi.org\/10.1186\/s13054-024-05224-3","journal-title":"Crit Care"},{"key":"8252_CR61","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/s2213-2600(22)00086-8","volume":"10","author":"AM Darie","year":"2022","unstructured":"Darie AM, Khanna N, Jahn K et al (2022) Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in randomized patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomized controlled trial. Lancet Respir Med 10:877\u2013887. https:\/\/doi.org\/10.1016\/s2213-2600(22)00086-8","journal-title":"Lancet Respir Med"},{"key":"8252_CR62","doi-asserted-by":"publisher","first-page":"7098","DOI":"10.1038\/s41467-024-51547-8","volume":"15","author":"G Abelenda-Alonso","year":"2024","unstructured":"Abelenda-Alonso G, Calatayud L, Rombauts A et al (2024) Multiplex real-time PCR in non-invasive respiratory samples to reduce antibiotic use in community-acquired pneumonia: a randomized trial. Nat Commun 15:7098. https:\/\/doi.org\/10.1038\/s41467-024-51547-8","journal-title":"Nat Commun"},{"issue":"12","key":"8252_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(24)00170-8","volume":"5","author":"A Virk","year":"2024","unstructured":"Virk A, Strasburg AP, Kies KD et al (2024) Rapid multiplex PCR panel for pneumonia in randomized patients with suspected pneumonia in the USA: a single-centre, open-label, pragmatic, randomized controlled trial. Lancet Microbe 5(12):100928. https:\/\/doi.org\/10.1016\/S2666-5247(24)00170-8","journal-title":"Lancet Microbe"},{"key":"8252_CR64","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1055\/s-0043-1778140","volume":"45","author":"M Ferrer","year":"2024","unstructured":"Ferrer M, De Pascale G, Tanzarella ES, Antonelli M (2024) Severe community-acquired pneumonia: noninvasive mechanical ventilation, intubation, and HFNT. Semin Respir Crit Care Med 45:169\u2013186. https:\/\/doi.org\/10.1055\/s-0043-1778140","journal-title":"Semin Respir Crit Care Med"},{"key":"8252_CR65","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jama.2016.0291","volume":"315","author":"G Bellani","year":"2016","unstructured":"Bellani G, Laffey JG, Pham T et al (2016) Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 315:788\u2013800. https:\/\/doi.org\/10.1001\/jama.2016.0291","journal-title":"JAMA"},{"key":"8252_CR66","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00134-023-07050-7","volume":"49","author":"G Grasselli","year":"2023","unstructured":"Grasselli G, Calfee CS, Camporota L et al (2023) ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies. Intensive Care Med 49:727\u2013759. https:\/\/doi.org\/10.1007\/s00134-023-07050-7","journal-title":"Intensive Care Med"},{"key":"8252_CR67","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1164\/rccm.201703-0548ST","volume":"195","author":"E Fan","year":"2017","unstructured":"Fan E, Del SL, Goligher EC et al (2017) An official American Thoracic Society\/European Society of Intensive Care Medicine\/Society of Critical Care Medicine clinical practice guideline: mechanical ventilation in adult patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 195:1253\u20131263. https:\/\/doi.org\/10.1164\/rccm.201703-0548ST","journal-title":"Am J Respir Crit Care Med"},{"key":"8252_CR68","doi-asserted-by":"publisher","first-page":"2101574","DOI":"10.1183\/13993003.01574-2021","volume":"59","author":"S Oczkowski","year":"2022","unstructured":"Oczkowski S, Ergan B, Bos L et al (2022) ERS clinical practice guidelines: high-flow nasal cannula in acute respiratory failure. Eur Respir J 59:2101574. https:\/\/doi.org\/10.1183\/13993003.01574-2021","journal-title":"Eur Respir J"},{"key":"8252_CR69","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/jama.2020.9524","volume":"324","author":"BL Ferreyro","year":"2020","unstructured":"Ferreyro BL, Angriman F, Munshi L et al (2020) Association of noninvasive oxygenation strategies with all-cause mortality in adults with acute hypoxemic respiratory failure. JAMA 324:57\u201367. https:\/\/doi.org\/10.1001\/jama.2020.9524","journal-title":"JAMA"},{"key":"8252_CR70","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1007\/s00134-012-2475-6","volume":"38","author":"A Carrillo","year":"2012","unstructured":"Carrillo A, Gonzalez-Diaz G, Ferrer M et al (2012) Non-invasive ventilation in community-acquired pneumonia and severe acute respiratory failure. Intensive Care Med 38:458\u2013466. https:\/\/doi.org\/10.1007\/s00134-012-2475-6","journal-title":"Intensive Care Med"},{"key":"8252_CR71","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1007\/s00134-020-06248-3","volume":"46","author":"A Combes","year":"2020","unstructured":"Combes A, Peek GJ, Hajage D et al (2020) ECMO for severe ARDS: systematic review and individual patient data meta-analysis. Intensive Care Med 46:2048\u20132057. https:\/\/doi.org\/10.1007\/s00134-020-06248-3","journal-title":"Intensive Care Med"},{"key":"8252_CR72","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1055\/s-0043-1778641","volume":"45","author":"M Bassetti","year":"2024","unstructured":"Bassetti M, Giacobbe DR, Magnasco L, Fantin A, Vena A, Castaldo N (2024) Antibiotic strategies for severe community-acquired pneumonia. Semin Respir Crit Care Med 45:187\u2013199. https:\/\/doi.org\/10.1055\/s-0043-1778641","journal-title":"Semin Respir Crit Care Med"},{"key":"8252_CR73","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ijantimicag.2019.05.023","volume":"54","author":"K Eljaaly","year":"2019","unstructured":"Eljaaly K, Wali H, Basilim A, Alharbi A, Asfour HZ (2019) Clinical cure with ceftriaxone versus ceftaroline or ceftobiprole in the treatment of staphylococcal pneumonia: a systematic review and meta-analysis. Int J Antimicrob Agents 54:149\u2013153. https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.05.023","journal-title":"Int J Antimicrob Agents"},{"key":"8252_CR74","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2147\/JEP.S259286","volume":"12","author":"J Sellar\u00e8s-Nadal","year":"2020","unstructured":"Sellar\u00e8s-Nadal J, Burgos J, Falc\u00f3 V, Almirante B (2020) Investigational and experimental drugs for community-acquired pneumonia: the current evidence. J Exp Pharmacol 12:529\u2013538","journal-title":"J Exp Pharmacol"},{"key":"8252_CR75","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1093\/jac\/dku033","volume":"69","author":"W Nie","year":"2014","unstructured":"Nie W, Li B, Xiu Q (2014) \u0392-Lactam\/macrolide dual therapy versus \u03b2-lactam monotherapy for the treatment of community-acquired pneumonia in adults: a systematic review and meta-analysis. J Antimicrob Chemother 69:1441\u20131446. https:\/\/doi.org\/10.1093\/jac\/dku033","journal-title":"J Antimicrob Chemother"},{"key":"8252_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106942","volume":"62","author":"N Kyprianou","year":"2023","unstructured":"Kyprianou N, Dakou I, Aktrar A et al (2023) Macrolides for better resolution of community-acquired pneumonia: a global meta-analysis of clinical outcomes with focus on microbial etiology. Int J Antimicrob Agents 62:106942. https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106942","journal-title":"Int J Antimicrob Agents"},{"key":"8252_CR77","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1001\/jamainternmed.2014.4887","volume":"174","author":"N Garin","year":"2014","unstructured":"Garin N, Genn\u00e9 D, Carballo S et al (2014) \u03b2-Lactam monotherapy vs \u03b2-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial. JAMA Intern Med 174:1894\u20131901. https:\/\/doi.org\/10.1001\/jamainternmed.2014.4887","journal-title":"JAMA Intern Med"},{"key":"8252_CR78","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S2213-2600(23)00412-5","volume":"12","author":"EJ Giamarellos-Bourboulis","year":"2024","unstructured":"Giamarellos-Bourboulis EJ, Siampanos A, Bolanou A et al (2024) Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a andomized, double-blind, placebo-controlled trial. Lancet Resp Med 12:294\u2013304. https:\/\/doi.org\/10.1016\/S2213-2600(23)00412-5","journal-title":"Lancet Resp Med"},{"key":"8252_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2024.107406","volume":"65","author":"K Akinosoglou","year":"2025","unstructured":"Akinosoglou K, Leventogiannis K, Tasouli E et al (2025) Clarithromycin for improved clinical outcomes in community-acquired pneumonia: a subgroup analysis of the ACCESS study. Int J Antimicrob Agents 65:107406. https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107406","journal-title":"Int J Antimicrob Agents"},{"key":"8252_CR80","doi-asserted-by":"publisher","first-page":"105034","DOI":"10.1016\/j.idnow.2025.105034","volume":"55","author":"A Dinh","year":"2025","unstructured":"Dinh A, Barbier F, Bedos JP et al (2025) Update of guidelines for management of community acquired pneumonia in adults by the French infectious disease society (SPILF) and the French-speaking society of respiratory diseases (SPLF). Endorsed by the French intensive care society (SRLF), the French microbiology society (SFM), the French radiology society (SFR) and the French emergency society (SFMU). Infect Dis Now 55:105034. https:\/\/doi.org\/10.1016\/j.idnow.2025.105034","journal-title":"Infect Dis Now"},{"key":"8252_CR81","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-025-08063-0","author":"JF Timsit","year":"2025","unstructured":"Timsit JF, Ling L, de Montmollin E et al (2025) Antibiotic therapy for\u00a0severe bacterial infections. Intensive Care Med. https:\/\/doi.org\/10.1007\/s00134-025-08063-0. (epub ahead of print)","journal-title":"Intensive Care Med"},{"key":"8252_CR82","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s00134-022-06684-3","volume":"48","author":"GU Meduri","year":"2022","unstructured":"Meduri GU, Shih MC, Bridges L et al (2022) Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia. Intensive Care Med 48:1009\u20131023. https:\/\/doi.org\/10.1007\/s00134-022-06684-3","journal-title":"Intensive Care Med"},{"key":"8252_CR83","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1056\/NEJMoa2215145","volume":"388","author":"PF Dequin","year":"2023","unstructured":"Dequin PF, Meziani F, Quenot JP et al (2023) Hydrocortisone in severe community-acquired pneumonia. N Engl J Med 388:1931\u20131941. https:\/\/doi.org\/10.1056\/NEJMoa2215145","journal-title":"N Engl J Med"},{"key":"8252_CR84","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s001134-025-07861-w","volume":"51","author":"DC Angus","year":"2025","unstructured":"REMAP-CAP Investigators, Angus DC (2025) Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia. The REMAP-CAP corticosteroid domain randomized clinical trial. Intensive Care Med 51:665\u2013680. https:\/\/doi.org\/10.1007\/s001134-025-07861-w","journal-title":"Intensive Care Med"},{"key":"8252_CR85","doi-asserted-by":"publisher","first-page":"P221","DOI":"10.1016\/S2213-2600(24)00405-3","volume":"13","author":"JM Smit","year":"2025","unstructured":"Smit JM, Van der Zee PA, Stoof SCM et al (2025) Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a data-driven analysis of randomised trials. Lancet Respir Med 13:P221\u2013P233. https:\/\/doi.org\/10.1016\/S2213-2600(24)00405-3","journal-title":"Lancet Respir Med"},{"key":"8252_CR86","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s00134-025-07912-2","volume":"51","author":"T Pitre","year":"2025","unstructured":"Pitre T, Pauley E, Chaudhuri D et al (2025) Corticosteroids for adult patients hospitalized with non-viral community-acquired pneumonia: a systematic review and meta-analysis. Intensive Care Med 51:917\u2013929. https:\/\/doi.org\/10.1007\/s00134-025-07912-2","journal-title":"Intensive Care Med"},{"key":"8252_CR87","doi-asserted-by":"publisher","first-page":"P366","DOI":"10.1016\/S2213-2600(23)00430-7","volume":"12","author":"N Heming","year":"2024","unstructured":"Heming N, Renault A, Kupermink E et al (2024) Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trial. Lancet Respir Med 12:P366\u2013P374. https:\/\/doi.org\/10.1016\/S2213-2600(23)00430-7","journal-title":"Lancet Respir Med"},{"key":"8252_CR88","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"Recovery Collaborative Group","year":"2021","unstructured":"Recovery Collaborative Group (2021) Dexamethasone in hospitalized patients with Covid-19. New Engl J Med 384:693\u2013704. https:\/\/doi.org\/10.1056\/NEJMoa2021436","journal-title":"New Engl J Med"},{"key":"8252_CR89","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010406.pub3","author":"L Lansbury","year":"2019","unstructured":"Lansbury L, Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Lim WS (2019) Corticosteroids as adjunctive therapy in the treatment of influenza. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD010406.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"8252_CR90","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJM199011223232104","volume":"323","author":"SA Bozette","year":"1990","unstructured":"Bozette SA, Sattler FR, Chiu J et al (1990) A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. New Engl J Med 323:1451\u20131457. https:\/\/doi.org\/10.1056\/NEJM199011223232104","journal-title":"New Engl J Med"},{"key":"8252_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(25)00125-0","author":"V Lemiale","year":"2025","unstructured":"Lemiale V, Resche-Rigon M, Zerbib Y et al (2025) Adjunctive corticosteroids in non-AIDS patients with severe Pneumocystis jirovecii pneumonia (PIC): a multicentre, double-blind, randomised controlled trial. Lancet Respir Med 2025;13:800-808.\u00a0https:\/\/doi.org\/10.1016\/S2213-2600(25)00125-0.","journal-title":"Lancet Respir Med"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-025-08252-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-025-08252-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-025-08252-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T15:59:30Z","timestamp":1769615970000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-025-08252-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["8252"],"URL":"https:\/\/doi.org\/10.1007\/s00134-025-08252-x","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"1 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"PFD declares that he has received funding from research programs run by the French Ministry of Health, as well as equipment loans from Aerogen and Fisher and Paykel. As a consultant, he has received fees from Aridis Pharmaceuticals. PP is a Section Editor for Intensive Care Medicine. He has not taken part in the review or selection process of this article. PP is a Section Editor for Intensive Care Medicine. He has not taken part in the review or selection process of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}